PharmEnable

Cambridge, United Kingdom

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

$7.5M raised

May 2023

Seed

Top Investors

Parkwalk AdvisorsMartlet CapitalMP Healthcare Venture ManagementPitch@PalaceO2h Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has PharmEnable raised?

PharmEnable has raised $7.5M in total funding. The most recent round was Seed. The last funding was announced in May 2023.

Who are PharmEnable's investors?

PharmEnable's investors include Parkwalk Advisors, Martlet Capital, MP Healthcare Venture Management, Pitch@Palace, O2h Ventures.

Where is PharmEnable headquartered?

PharmEnable is headquartered in Cambridge, United Kingdom.

What does PharmEnable do?

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

What stage is PharmEnable at?

PharmEnable is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 22, 2023.

MLA

"PharmEnable — Funding & Investors." VCBacked, May 22, 2023, https://www.vcbacked.co/company/pharmenable. Accessed June 3, 2026.

APA

VCBacked. (2023). PharmEnable — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/pharmenable

Wikipedia (cite web)

{{cite web |title=PharmEnable — Funding & Investors |url=https://www.vcbacked.co/company/pharmenable |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 22, 2023.